The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s ...

Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by ...

The journey of rare disease patients and their families can be a long one marked by misdiagnoses, and so it is for those who have the ultra-rare disorder with the abbreviated name PMM2-CDG. This ...

Anthem’s newly-formed pharmacy benefit manager acquired pharmacy startup Zipdrug. The deal will give Anthem access to Zipdrug’s services to facilitate medication delivery and improve adherence. Anthem ...

The rise of AI changes many spheres of life, with a projected growth rate of nearly 37% by 2030 — while healthcare is expected to see the most impact from AI use with a long-term adoption rate of 40%.

Serve You Rx, a pharmacy benefit manager, has added two recently approved biosimilars to Stelara to its formulary, the company announced Thursday. Milwaukee, Wisconsin-based Serve You Rx is an ...

Beanstalk Benefits, a startup that allows employees to build their own health benefits, launched Thursday with $7.5 million in funding. The startup was built at Redesign Health, a healthcare ...

As employers brace for significant healthcare cost increases in 2026, many are seeking out innovative strategies to manage the impact. This comes from the Business Group on Health’s newly released ...

SmarterDx closed a $50 million Series B funding round on Tuesday, bringing the startup’s total funding to date to $71 million. The New York-based company is a healthcare AI startup that provides ...

Americans’ trust in the overall healthcare system is dwindling — but experts believe it can be rebuilt. Public trust in the U.S. healthcare system fell from 71.5% in 2020 to 40.1% in 2024, according ...

Digital solutions have greatly expanded access to mental health support, though they’re not always reaching the people who need it the most, such as youth in rural, low-income and marginalized ...

A Pfizer gene therapy for hemophilia A reduced bleeding rates in patients with the inherited blood disorder, meeting goals of its Phase 3 study. The preliminary results announced Wednesday are ...